Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Maastricht University Medical Center University of Tilburg |
---|---|
Information provided by: | Maastricht University Medical Center |
ClinicalTrials.gov Identifier: | NCT00504621 |
A number of studies have shown that the quality of life of two common interstitial lung diseases (ild), sarcoidosis and pulmonary fibrosis patients, is impaired and that fatigue is a substantial problem for those patients. Furthermore, breathlessness is an additional major problem in pulmonary fibrosis. In the field of cardiovascular disease and breast cancer, personality factors have shown to play a role in patient's morbidity, mortality, quality of life, fatigue, depressive symptoms, and one study showed a predictive role of personality factors in health care consumption. No studies examining personality factors have been performed in sarcoidosis or pulmonary fibrosis. Therefore, the aim of the present study is to examine the role of personality factors as predictors of fatigue, quality of life, prognosis, and health care consumption in sarcoidosis and pulmonary fibrosis. In this study a number of possible moderators, such as social support, will also be examined, aiming to get a full picture of the relationship between the various factors examined. Known and new sarcoidosis and pulmonary fibrosis patients (inclusion period 1 year) of ild care team of the outpatient clinic of the department of Respiratory Medicine of the University Hospital Maastricht will be asked to participate through completing questionnaires at baseline and every six months for 18 months, and allowing the researchers access to their medical records for the purpose of this study.
Condition |
---|
Sarcoidosis Pulmonary Fibrosis |
Study Type: | Observational |
Study Design: | Cross-Sectional |
Official Title: | The Influence of Personality on Quality of Life, Fatigue, Prognosis, and Health Care Consumption in Pulmonary Fibrosis and Sarcoidosis |
Enrollment: | 450 |
Study Start Date: | August 2007 |
Estimated Study Completion Date: | January 2009 |
Groups/Cohorts |
---|
sarcoidosis
Sarcoidosis known by the ild care team of the outpatient clinic of the department of Respiratory Medicine of the University Hospital Maastricht as well as new patients attending the out-patient clinic from August 2007 to January 2009
|
pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) patients known by the ild care team of the outpatient clinic of the department of Respiratory Medicine of the University Hospital Maastricht as well as new patients attending the out-patient clinic from August 2007 to January 2009
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Sarcoidosis patients diagnosed according to WASOG guidelines and IPF patients diagnosed according ATS guidelines.
Inclusion Criteria:
Exclusion Criteria:
Netherlands | |
Maastricht University Medical Center | |
Maastricht, Netherlands, 6200 AZ |
Study Chair: | Marjolein Drent, Md, PhD | Maastricht University Medical Center |
Study Chair: | Jolanda de Vries, PhD | Tilburg University |
Principal Investigator: | Marjon Elfferich, MSc | Gelderse Vallei Ziekenhuis Ede |
Responsible Party: | Maastricht University Medical Center ( Marjolein Drent, Md, PhD ) |
Study ID Numbers: | MEC 07-4-015 |
Study First Received: | July 19, 2007 |
Last Updated: | January 6, 2009 |
ClinicalTrials.gov Identifier: | NCT00504621 History of Changes |
Health Authority: | Netherlands: The Central Committee on Research Involving Human Subjects (CCMO) |
personality fatigue quality of life health care consumption |
Lymphatic Diseases Lung Diseases, Interstitial Fatigue Respiratory Tract Diseases Fibrosis |
Lung Diseases Quality of Life Sarcoidosis Lymphoproliferative Disorders Pulmonary Fibrosis |
Lymphatic Diseases Lung Diseases, Interstitial Pathologic Processes Respiratory Tract Diseases Fibrosis |
Lung Diseases Sarcoidosis Lymphoproliferative Disorders Pulmonary Fibrosis |